Cargando…

Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease

Machado-Joseph disease (MJD) is an inherited neurodegenerative disease, caused by a CAG repeat expansion within the coding region of ATXN3 gene, and which currently lacks effective treatment. In this work we tested the therapeutic efficacy of chronic treatment with valproic acid (VPA) (200mg/kg), a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esteves, Sofia, Duarte-Silva, Sara, Naia, Luana, Neves-Carvalho, Andreia, Teixeira-Castro, Andreia, Rego, Ana Cristina, Silva-Fernandes, Anabela, Maciel, Patrícia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624233/ https://www.ncbi.nlm.nih.gov/pubmed/26505994 http://dx.doi.org/10.1371/journal.pone.0141610

Ejemplares similares

Profiling Microglia in a Mouse Model of Machado–Joseph Disease
por: Campos, Ana Bela, et al.
Publicado: (2022)

Microglial Depletion Has No Impact on Disease Progression in a Mouse Model of Machado–Joseph Disease
por: Campos, Ana Bela, et al.
Publicado: (2022)

Mitochondrial Dysfunction and Decreased Cytochrome c in Cell and Animal Models of Machado–Joseph Disease
por: Almeida, Filipa, et al.
Publicado: (2023)

GST-4-Dependent Suppression of Neurodegeneration in C. elegans Models of Parkinson’s and Machado-Joseph Disease by Rapeseed Pomace Extract Supplementation
por: Pohl, Franziska, et al.
Publicado: (2019)

Trehalose alleviates the phenotype of Machado–Joseph disease mouse models
por: Santana, Magda M., et al.
Publicado: (2020)

Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease
por: Duarte-Neves, Joana, et al.
Publicado: (2021)

Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease
por: Miranda, Catarina Oliveira, et al.
Publicado: (2022)

Familial spontaneous pneumothorax and Machado–Joseph disease
por: Pelayo, Jerald, et al.
Publicado: (2020)

Caloric restriction blocks neuropathology and motor deficits in Machado–Joseph disease mouse models through SIRT1 pathway
por: Cunha-Santos, Janete, et al.
Publicado: (2016)

Cerebellar Rotation Abnormalities Observed in Machado-Joseph Disease
por: Nomura, Taichi, et al.
Publicado: (2020)

Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease
por: Ferreira, Ana F., et al.
Publicado: (2023)

Machado-Joseph Disease: from first descriptions to new perspectives
por: Bettencourt, Conceição, et al.
Publicado: (2011)

Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment
por: Onofre, Isabel, et al.
Publicado: (2016)

T2-hyperintensity in the internal globus pallidus in Machado-Joseph disease
por: Meira, Alex T., et al.
Publicado: (2023)

Clinical manifestations and gene mutation in a case of Machado-Joseph disease★
por: Zhang, Bin, et al.
Publicado: (2012)

State biomarkers for Machado Joseph disease: Validation, feasibility and responsiveness to change
por: Furtado, Gabriel Vasata, et al.
Publicado: (2019)

Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets
por: Zeng, Chenming, et al.
Publicado: (2020)

Sentinel Node Biopsy and Lumpectomy in a Patient with Machado–Joseph Disease
por: Aldawoodi, N. N., et al.
Publicado: (2019)

RNA Interference Mitigates Motor and Neuropathological Deficits in a Cerebellar Mouse Model of Machado-Joseph Disease
por: Nóbrega, Clévio, et al.
Publicado: (2014)

Ataxin-3 and Its E3 Partners: Implications for Machado–Joseph Disease
por: Durcan, Thomas M., et al.
Publicado: (2013)

Nystagmus as an early ocular alteration in Machado-Joseph disease (MJD/SCA3)
por: Raposo, Mafalda, et al.
Publicado: (2014)

Dystonia in Patients with Spinocerebellar Ataxia 3 - Machado-Joseph disease: An Underestimated Diagnosis?
por: Catai, Ligia Maria Perrucci, et al.
Publicado: (2018)

Is the High Frequency of Machado-Joseph Disease in China Due to New Mutational Origins?
por: Li, Tianjiao, et al.
Publicado: (2019)

The Homogeneous Azorean Machado-Joseph Disease Cohort: Characterization and Contributions to Advances in Research
por: Lima, Manuela, et al.
Publicado: (2023)

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
por: de Assis, Adriano M., et al.
Publicado: (2017)

What is the best way to keep walking and moving around for individuals with Machado-Joseph disease? A scoping review through the lens of Aboriginal families with Machado-Joseph disease in the Top End of Australia
por: Carr, Jennifer J, et al.
Publicado: (2019)

Normal ATXN3 Allele but Not CHIP Polymorphisms Modulates Age at Onset in Machado–Joseph Disease
por: França, Marcondes C., et al.
Publicado: (2012)

Machado-Joseph disease in a Sudanese family links East Africa to Portuguese families and allows reestimation of ancestral age of the Machado lineage
por: Martins, Sandra, et al.
Publicado: (2023)

High frequency of Machado-Joseph disease identified in Southeastern Chinese kindreds with spinocerebellar ataxia
por: Gan, Shi-Rui, et al.
Publicado: (2010)

Gabapentin for complex regional pain syndrome in Machado-Joseph disease: a case report
por: Lo, Yang-Ching, et al.
Publicado: (2011)

Neural correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph disease
por: Hernandez-Castillo, Carlos R., et al.
Publicado: (2017)

Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
por: Martier, Raygene, et al.
Publicado: (2019)

Remote Measurement of Functional Status in Pre-symptomatic and Symptomatic Individuals with Machado-Joseph Disease
por: Miglorini, Elaine Cristina, et al.
Publicado: (2022)

Recurrent divergence-insufficiency esotropia in Machado-Joseph disease (spinocerebellar ataxia type 3)
por: Stallworth, Jeannette Y., et al.
Publicado: (2022)

Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report
por: Bettencourt, Conceição, et al.
Publicado: (2011)

Genetic counseling and presymptomatic testing programs for Machado-Joseph Disease: lessons from Brazil and Portugal
por: Schuler-Faccini, Lavínia, et al.
Publicado: (2014)

The Machado–Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53
por: Liu, Hongmei, et al.
Publicado: (2016)

A Variant in Genes of the NPY System as Modifier Factor of Machado-Joseph Disease in the Chinese Population
por: Ding, Dongxue, et al.
Publicado: (2022)

Implications of specific lysine residues within ataxin-3 for the molecular pathogenesis of Machado-Joseph disease
por: Pereira Sena, Priscila, et al.
Publicado: (2023)

Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP(3)R2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3
por: Cunha-Garcia, Daniela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0lg12bfq3mi7a0madlap2i83rf